Symbols / HOOK
HOOK Chart
About
HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunetherapeutics targeting infectious diseases based on its proprietary arenavirus platform. The company's immuno-oncology pipeline includes HB-700, a novel next-generation multi-KRAS mutant-targeting investigational immunotherapy for the treatment of KRAS mutated cancers, including lung, colorectal, and pancreatic cancers; Eseba-vec, an investigational immunotherapeutic agent in clinical development for the treatment of Human Papillomavirus 16-positive (HPV16+) head and neck cancers with enrollment completed in a Phase 1/2 clinical trial; and HB-300, which targets self-antigens for the treatment of prostate cancer. It is also developing HB-400 for the treatment of Hepatitis B that is in Phase I of clinical trial; and HB-500 for the treatment of Human Immunodeficiency Virus (HIV) that is in Phase I of clinical trial. The company has a collaboration and license agreement with Gilead Sciences, Inc. to collaborate on preclinical research programs to evaluate potential vaccine products for the treatment, cure, diagnosis, or prevention of the hepatitis B virus (HBV) and the HIV. HOOKIPA Pharma Inc. was incorporated in 2011 and is headquartered in New York, New York.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Biotechnology | Market Cap | 12.58M |
| Enterprise Value | -26.88M | Income | -73.31M | Sales | 9.35M |
| Book/sh | 2.71 | Cash/sh | 3.18 | Dividend Yield | — |
| Payout | 0.00% | Employees | 82 | IPO | — |
| P/E | — | Forward P/E | -0.19 | PEG | — |
| P/S | 1.34 | P/B | 0.38 | P/C | — |
| EV/EBITDA | 0.37 | EV/Sales | -2.88 | Quick Ratio | 2.92 |
| Current Ratio | 3.61 | Debt/Eq | 1.75 | LT Debt/Eq | — |
| EPS (ttm) | -4.83 | EPS next Y | -5.43 | EPS Growth | — |
| Revenue Growth | -94.50% | Earnings | 2025-05-15 16:00 | ROA | -45.20% |
| ROE | -105.79% | ROIC | — | Gross Margin | 0.00% |
| Oper. Margin | -8.85% | Profit Margin | 0.00% | Shs Outstand | 9.93M |
| Shs Float | 12.34M | Short Float | 0.45% | Short Ratio | 0.57 |
| Short Interest | — | 52W High | 1.88 | 52W Low | 0.72 |
| Beta | 0.89 | Avg Volume | 22.00K | Volume | 590.00 |
| Target Price | — | Recom | None | Prev Close | $1.01 |
| Price | $1.02 | Change | 0.99% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
$1.02
Latest analyst target
3. DCF / Fair value
$-59.47
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$1.02
Low
—
High
—
Mean
—
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2025-01-10 | down | HC Wainwright & Co. | Buy → Neutral | — |
| 2024-12-20 | down | RBC Capital | Outperform → Sector Perform | $2 |
| 2024-11-21 | main | JMP Securities | Market Outperform → Market Outperform | $7 |
| 2024-11-15 | main | RBC Capital | Outperform → Outperform | $48 |
| 2024-08-09 | main | JMP Securities | Market Outperform → Market Outperform | $24 |
| 2024-07-26 | main | JMP Securities | Market Outperform → Market Outperform | $23 |
| 2024-06-05 | main | HC Wainwright & Co. | Buy → Buy | $6 |
| 2024-05-21 | reit | RBC Capital | Outperform → Outperform | $5 |
| 2024-04-26 | main | HC Wainwright & Co. | Buy → Buy | $5 |
| 2024-03-25 | reit | RBC Capital | Outperform → Outperform | $5 |
| 2024-03-25 | reit | HC Wainwright & Co. | Buy → Buy | $7 |
| 2024-01-30 | main | RBC Capital | Outperform → Outperform | $5 |
| 2023-09-27 | reit | RBC Capital | Outperform → Outperform | $7 |
| 2023-09-06 | reit | Truist Securities | Buy → Buy | $4 |
| 2023-08-11 | main | HC Wainwright & Co. | Buy → Buy | $7 |
| 2023-06-30 | reit | RBC Capital | Outperform → Outperform | $7 |
| 2023-06-05 | main | Morgan Stanley | Equal-Weight → Equal-Weight | $2 |
| 2023-05-12 | reit | HC Wainwright & Co. | Buy → Buy | $8 |
| 2023-03-20 | main | Truist Securities | — → Buy | $4 |
| 2023-03-16 | reit | HC Wainwright & Co. | — → Buy | $8 |
- Judgment Sticks: Tesla Stock (NASDAQ:TSLA) Slips as Tesla on the Hook for $243 Million - TipRanks Sat, 21 Feb 2026 17
- NeoTrail picks up HOOKIPA’s next-gen cancer vaccines in undisclosed deal - Stock Titan ue, 03 Feb 2026 08
- Off The Hook shares begin trading below IPO price on NYSE American - Investing.com hu, 13 Nov 2025 08
- Off The Hook YS Inc. Announces Pricing of its Initial Public Offering - Yahoo Finance Wed, 12 Nov 2025 08
- How a yacht-flipping business went from college side hustle to $68M publicly traded company - New York Post ue, 27 Jan 2026 08
- Off The Hook YS: Details & Strategy for the IPO (OTH) - tradingcalendar.com ue, 04 Nov 2025 08
- Meta Shares Tips on Reels Hooks, Creative Diversification in Ads and Threads - Social Media Today Wed, 17 Dec 2025 08
- Off the Hook stock soars after announcing $1 million share buyback - Investing.com hu, 08 Jan 2026 08
- Taxpayer impact from public pension investment losses - Newsday ue, 29 Apr 2025 07
- HOOKIPA Pharma (OTC: HOOK) closes sale of HB-400 and HB-500 program assets to Gilead - Stock Titan Fri, 31 Oct 2025 07
- Gilead (GILD) to Acquire HOOK for $10 million - Yahoo Finance Fri, 23 May 2025 07
- Off The Hook yacht wholesaler prices IPO at $4 per share - Investing.com Wed, 12 Nov 2025 08
- Off The Hook YS (NYSE American: OTH) prices IPO at $4 with 3.75M shares offered - Stock Titan Wed, 12 Nov 2025 08
- HOOKIPA Pharma Announces Intention to Voluntarily Delist and Deregister its Common Stock - Yahoo Finance Fri, 18 Jul 2025 07
- Off the Hook stock soars after announcing $1 million share buyback - Investing.com Nigeria hu, 08 Jan 2026 15
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 25172 | 20684 | — | Sale at price 0.82 per share. | PETERS MALTE | Chief Executive Officer | — | 2025-08-19 00:00:00 | D |
| 1 | 13609 | 12520 | — | Sale at price 0.92 per share. | COELHO MARY THERESA | Chief Financial Officer | — | 2025-07-22 00:00:00 | D |
| 2 | 29176 | 26842 | — | Sale at price 0.92 per share. | PETERS MALTE | Chief Executive Officer | — | 2025-07-22 00:00:00 | D |
| 3 | 69875 | — | — | Stock Award(Grant) at price 0.00 per share. | COELHO MARY THERESA | Chief Financial Officer | — | 2024-07-22 00:00:00 | D |
| 4 | 108695 | — | — | Stock Award(Grant) at price 0.00 per share. | PETERS MALTE | Chief Executive Officer | — | 2024-07-22 00:00:00 | D |
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | -13.34K | -2.68M | 0.00 | 0.00 |
| TaxRateForCalcs | 0.00 | 0.21 | 0.21 | 0.00 |
| NormalizedEBITDA | -34.19M | -64.58M | -60.40M | -70.13M |
| TotalUnusualItems | -6.67M | -12.77M | 0.00 | 0.00 |
| TotalUnusualItemsExcludingGoodwill | -6.67M | -12.77M | 0.00 | 0.00 |
| NetIncomeFromContinuingOperationNetMinorityInterest | -43.50M | -81.58M | -64.92M | -75.67M |
| ReconciledDepreciation | 2.75M | 3.55M | 3.60M | 4.64M |
| EBITDA | -40.85M | -77.34M | -60.40M | -70.13M |
| EBIT | -43.61M | -80.89M | -64.00M | -74.77M |
| NetInterestIncome | 3.70M | 4.98M | 946.00K | -871.00K |
| InterestExpense | 2.00K | 317.00K | 687.00K | 898.00K |
| InterestIncome | 3.70M | 5.29M | 1.63M | 27.00K |
| NormalizedIncome | -36.85M | -71.49M | -64.92M | -75.67M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -43.50M | -81.58M | -64.92M | -75.67M |
| TotalExpenses | 81.34M | 93.86M | 79.49M | 90.40M |
| TotalOperatingIncomeAsReported | -51.45M | -97.69M | -73.16M | -81.67M |
| DilutedAverageShares | 12.54M | 9.45M | 6.56M | 6.56M |
| BasicAverageShares | 12.54M | 9.45M | 6.56M | 6.56M |
| DilutedEPS | -3.47 | -8.63 | -9.90 | -23.00 |
| BasicEPS | -3.47 | -8.63 | -9.90 | -23.00 |
| DilutedNIAvailtoComStockholders | -43.50M | -81.58M | -64.92M | -75.67M |
| NetIncomeCommonStockholders | -43.50M | -81.58M | -64.92M | -75.67M |
| NetIncome | -43.50M | -81.58M | -64.92M | -75.67M |
| NetIncomeIncludingNoncontrollingInterests | -43.50M | -81.58M | -64.92M | -75.67M |
| NetIncomeContinuousOperations | -43.50M | -81.58M | -64.92M | -75.67M |
| TaxProvision | -106.00K | 368.00K | 230.00K | 1.00K |
| PretaxIncome | -43.61M | -81.21M | -64.69M | -75.66M |
| OtherIncomeExpense | -9.92M | -12.45M | -392.00K | -2.84M |
| OtherNonOperatingIncomeExpenses | -3.25M | 313.00K | -392.00K | -2.84M |
| SpecialIncomeCharges | -6.67M | -12.77M | 0.00 | 0.00 |
| WriteOff | 4.00M | 12.77M | 0.00 | 0.00 |
| RestructuringAndMergernAcquisition | 2.66M | 0.00 | 0.00 | |
| NetNonOperatingInterestIncomeExpense | 3.70M | 4.98M | 946.00K | -871.00K |
| InterestExpenseNonOperating | 2.00K | 317.00K | 687.00K | 898.00K |
| InterestIncomeNonOperating | 3.70M | 5.29M | 1.63M | 27.00K |
| OperatingIncome | -37.39M | -73.73M | -65.24M | -71.95M |
| OperatingExpense | 81.34M | 93.86M | 79.49M | 90.40M |
| OtherOperatingExpenses | -7.40M | -11.19M | -7.92M | -9.72M |
| ResearchAndDevelopment | 68.51M | 86.42M | 68.64M | 82.85M |
| SellingGeneralAndAdministration | 20.23M | 18.63M | 18.76M | 17.27M |
| GeneralAndAdministrativeExpense | 18.76M | 17.27M | ||
| OtherGandA | 18.76M | 17.27M | ||
| TotalRevenue | 43.95M | 20.13M | 14.25M | 18.45M |
| OperatingRevenue | 43.95M | 20.13M | 14.25M | 18.45M |
| Line Item | 2023-12-31 | |||
|---|---|---|---|---|
| TreasurySharesNumber | 0.00 | |||
| OrdinarySharesNumber | 12.05M | 12.05M | 7.63M | 6.56M |
| ShareIssued | 12.05M | 12.05M | 7.63M | 6.56M |
| TotalDebt | 875.00K | 6.56M | 6.50M | 10.62M |
| TangibleBookValue | 51.21M | 89.86M | 102.52M | 89.59M |
| InvestedCapital | 51.21M | 90.98M | 105.02M | 94.60M |
| WorkingCapital | 56.01M | 105.13M | 111.56M | 74.48M |
| NetTangibleAssets | 51.21M | 89.86M | 102.52M | 89.59M |
| CapitalLeaseObligations | 875.00K | 5.44M | 4.00M | 5.61M |
| CommonStockEquity | 51.21M | 89.86M | 102.52M | 89.59M |
| TotalCapitalization | 51.21M | 89.86M | 103.43M | 91.81M |
| TotalEquityGrossMinorityInterest | 51.21M | 89.86M | 102.52M | 89.59M |
| StockholdersEquity | 51.21M | 89.86M | 102.52M | 89.59M |
| GainsLossesNotAffectingRetainedEarnings | -5.09M | -7.93M | -7.16M | -4.78M |
| OtherEquityAdjustments | -5.09M | -7.93M | -7.16M | -4.78M |
| RetainedEarnings | -412.76M | -369.26M | -287.68M | -222.77M |
| AdditionalPaidInCapital | 469.06M | 467.05M | 397.35M | 317.13M |
| CapitalStock | 1.00K | 1.00K | 5.00K | 3.00K |
| CommonStock | 1.00K | 1.00K | 5.00K | 3.00K |
| PreferredStock | 0.00 | 0.00 | 0.00 | 0.00 |
| TotalLiabilitiesNetMinorityInterest | 31.33M | 71.48M | 67.94M | 36.45M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 6.68M | 29.49M | 32.30M | 8.80M |
| OtherNonCurrentLiabilities | 5.63M | 6.02M | 3.42M | 2.65M |
| NonCurrentDeferredLiabilities | 725.00K | 19.67M | 25.66M | 21.00K |
| NonCurrentDeferredRevenue | 725.00K | 19.67M | 25.66M | 21.00K |
| LongTermDebtAndCapitalLeaseObligation | 323.00K | 3.80M | 3.22M | 6.13M |
| LongTermCapitalLeaseObligation | 323.00K | 3.80M | 2.31M | 3.91M |
| LongTermDebt | 911.00K | 2.22M | ||
| CurrentLiabilities | 24.65M | 41.99M | 35.63M | 27.65M |
| CurrentDeferredLiabilities | 4.76M | 14.68M | 15.98M | 6.23M |
| CurrentDeferredRevenue | 4.76M | 14.68M | 15.98M | 6.23M |
| CurrentDebtAndCapitalLeaseObligation | 552.00K | 2.76M | 3.28M | 4.50M |
| CurrentCapitalLeaseObligation | 552.00K | 1.64M | 1.69M | 1.70M |
| CurrentDebt | 1.12M | 1.59M | 2.79M | |
| OtherCurrentBorrowings | 1.12M | 1.59M | 2.79M | |
| PensionandOtherPostRetirementBenefitPlansCurrent | 267.00K | 250.00K | ||
| PayablesAndAccruedExpenses | 19.34M | 24.55M | 16.37M | 16.93M |
| CurrentAccruedExpenses | 10.65M | 11.68M | 10.65M | 8.17M |
| Payables | 8.69M | 12.87M | 5.72M | 8.76M |
| TotalTaxPayable | 0.00 | 367.00K | 230.00K | 0.00 |
| IncomeTaxPayable | 0.00 | 367.00K | 230.00K | 0.00 |
| AccountsPayable | 8.69M | 12.50M | 5.49M | 8.76M |
| TotalAssets | 82.55M | 161.34M | 170.45M | 126.05M |
| TotalNonCurrentAssets | 1.88M | 14.22M | 23.26M | 23.91M |
| OtherNonCurrentAssets | 816.00K | 1.01M | 1.28M | 1.79M |
| NetPPE | 1.06M | 13.21M | 21.98M | 22.11M |
| AccumulatedDepreciation | -5.89M | -9.82M | -7.78M | -6.37M |
| GrossPPE | 6.95M | 23.04M | 29.75M | 28.48M |
| Leases | 3.10M | 3.30M | 3.16M | 3.35M |
| ConstructionInProgress | 8.00K | 212.00K | 10.57M | 7.75M |
| OtherProperties | 885.00K | 14.20M | 11.41M | 12.79M |
| MachineryFurnitureEquipment | 2.96M | 3.31M | 2.66M | 2.53M |
| BuildingsAndImprovements | 5.76M | |||
| LandAndImprovements | 0.00 | 2.02M | 1.96M | 2.07M |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 80.67M | 147.12M | 147.20M | 102.14M |
| OtherCurrentAssets | 15.00M | 10.75M | 12.16M | 14.48M |
| AssetsHeldForSaleCurrent | 2.22M | 0.00 | ||
| RestrictedCash | 98.00K | 0.00 | 537.00K | 566.00K |
| PrepaidAssets | 14.48M | |||
| Receivables | 23.67M | 19.27M | 22.01M | 21.17M |
| OtherReceivables | 23.38M | 18.76M | 15.48M | 14.27M |
| AccountsReceivable | 290.00K | 511.00K | 6.53M | 6.89M |
| CashCashEquivalentsAndShortTermInvestments | 39.68M | 117.10M | 112.49M | 65.92M |
| CashAndCashEquivalents | 39.68M | 117.10M | 112.49M | 65.92M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -77.17M | -61.68M | -25.01M | -78.60M |
| RepaymentOfDebt | -1.14M | -1.75M | -2.85M | -438.00K |
| IssuanceOfCapitalStock | 0.00 | 67.57M | 75.32M | 203.00K |
| CapitalExpenditure | -194.00K | -4.16M | -5.02M | -12.58M |
| InterestPaidSupplementalData | 2.00K | 14.00K | 32.00K | 48.00K |
| IncomeTaxPaidSupplementalData | 1.00K | 403.00K | 1.00K | 1.00K |
| EndCashPosition | 39.89M | 117.52M | 113.44M | 66.91M |
| BeginningCashPosition | 117.52M | 113.44M | 66.91M | 143.18M |
| EffectOfExchangeRateChanges | 813.00K | 90.00K | -725.00K | 2.57M |
| ChangesInCash | -78.45M | 3.99M | 47.26M | -78.83M |
| FinancingCashFlow | -1.28M | 65.67M | 72.27M | -235.00K |
| CashFlowFromContinuingFinancingActivities | -1.28M | 65.67M | 72.27M | -235.00K |
| NetOtherFinancingCharges | -135.00K | -149.00K | -195.00K | |
| NetPreferredStockIssuance | 0.00 | 18.53M | 29.62M | 0.00 |
| PreferredStockIssuance | 0.00 | 18.53M | 29.62M | 0.00 |
| NetCommonStockIssuance | 0.00 | 49.04M | 45.69M | 203.00K |
| CommonStockIssuance | 0.00 | 49.04M | 45.69M | 203.00K |
| NetIssuancePaymentsOfDebt | -1.14M | -1.75M | -2.85M | -438.00K |
| NetLongTermDebtIssuance | -1.14M | -1.75M | -2.85M | -438.00K |
| LongTermDebtPayments | -1.14M | -1.75M | -2.85M | -438.00K |
| InvestingCashFlow | -194.00K | -4.16M | -5.02M | -12.58M |
| CashFlowFromContinuingInvestingActivities | -194.00K | -4.16M | -5.02M | -12.58M |
| NetPPEPurchaseAndSale | -194.00K | -4.16M | -5.02M | -12.58M |
| PurchaseOfPPE | -194.00K | -4.16M | -5.02M | -12.58M |
| OperatingCashFlow | -76.98M | -57.52M | -20.00M | -66.02M |
| CashFlowFromContinuingOperatingActivities | -76.98M | -57.52M | -20.00M | -66.02M |
| ChangeInWorkingCapital | -42.25M | 5.33M | 36.11M | -3.86M |
| ChangeInOtherWorkingCapital | -27.54M | -8.26M | 35.51M | 1.42M |
| ChangeInOtherCurrentLiabilities | -1.59M | 1.10M | -38.00K | -2.00M |
| ChangeInOtherCurrentAssets | 304.00K | 424.00K | 416.00K | |
| ChangeInPayablesAndAccruedExpense | -2.40M | 6.99M | 511.00K | 5.63M |
| ChangeInAccruedExpense | -828.00K | 490.00K | 2.51M | 4.78M |
| ChangeInPayable | -1.57M | 6.50M | -2.00M | 858.00K |
| ChangeInAccountPayable | -1.57M | 6.50M | -2.00M | 858.00K |
| ChangeInPrepaidAssets | -5.25M | 2.04M | 2.43M | -7.09M |
| ChangeInReceivables | -5.46M | 3.45M | -2.30M | -2.24M |
| ChangesInAccountReceivables | 524.00K | 6.18M | -341.00K | -1.94M |
| OtherNonCashItems | 64.00K | 160.00K | 1.23M | |
| StockBasedCompensation | 2.01M | 2.35M | 5.04M | 7.64M |
| AssetImpairmentCharge | 4.00M | 12.77M | 0.00 | 0.00 |
| DepreciationAmortizationDepletion | 2.75M | 3.55M | 3.60M | 4.64M |
| DepreciationAndAmortization | 2.75M | 3.55M | 3.60M | 4.64M |
| NetIncomeFromContinuingOperations | -43.50M | -81.58M | -64.92M | -75.67M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for HOOK
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|